Credit Guides And Credit Services

A Congressional investigation of the money that drug companies give as supposed educational grants has found that the payments are growing rapidly and are sometimes steered by marketing executives to doctors and groups who push unapproved uses of drugs.

Credit Pacific Service Union Twenty-three drug makers spent a total of $1.47 billion in 2004 on educational grants, or an average of $64 million per company, according to the Senate Finance Committee. That number was a 20 percent increase from the total in 2003, which was $1.23 billion.

There is no minimum credit score. Companies will take different factors into account when making the decision to grant credit, depending on their specific credit granting policies and appetite for risk. The acceptable credit score range is specific to the company that is granting you credit. So, if one company declines you for credit this does not mean that another will also decline you for credit.

Credit First Service Union The committee did not estimate what percentage of those grants were instead used for marketing purposes. But in a letter sent Monday to Johnson & Johnson, the committee suggested that the use of educational grants to further marketing aims was widespread in the industry. The committee also sent letters to most other major drug makers this week, seeking more information about their use of educational grants.

Looking for a credit card Compare the top UK credit cards on uSwitch.com, the free and impartial comparison service and apply online.

Card Credit Mobile Service The investigation is being directed by Senator Charles E. Grassley, Republican of Iowa, and Senator Max Baucus, Democrat from Montana, who are the chairman and ranking minority member, respectively, of the committee.

Impartial guide about credit card types available in the UK. Ensure you choose the right credit card type for you and save money with uSwitch.com

Card Credit Discover Service "It's hard to see how you could call some of these grants 'educational,' " Mr. Grassley said in an interview.

Credit Builder is an optional service that is made available to you at no additional cost as part of the AccountNow bill payment service. Credit Builder is only a service that provides your payment history to credit reporting agencies. Credit Builder does not improve or repair your credit record, credit history or credit rating. It also does not provide advice or assistance for the improvement or repair of your credit record, credit history or credit rating. For rmation, see Credit Builder Terms and Conditions.

Credit Public Service Union Mr. Baucus added, "If drug companies are crossing the line with these grants and influencing providers to make treatment decisions they might not otherwise make, that's a problem and we're going to tackle that."

Loan amount (£) - - 5 Years 10 Years 15 Years 25 Years Bad Credit Loans Freedom from Nightmares of Bad Credit Score Loans granted despite a borrower's poor credit record are called Bad Credit Loans. These loans can be helpful in meeting urgent monetary requirements and improving one's credit profile. A credit score is one of the benchmarks against which lenders will judge the feasibility of lending you money.

Card Credit Processing Service The investigation is part of a growing reassessment by federal legislators and prosecutors of the ways that drug makers are said to encourage doctors to prescribe medicines for uses not approved by federal drug regulators.

Center Credit Service Union Although doctors are allowed to prescribe federally approved drugs for any purposes they see fit, companies are allowed to market drugs only for their specifically approved uses. But in years past, at least, drug makers have given grants to doctors, medical societies and patient groups that do promote unapproved, or off-label uses.

Card Credit Service Wireless There is no doubt that off-label use of drugs is big business for the pharmaceutical industry. It has been estimated that more than half of all prescriptions written nationwide are for off-label uses.

Credit Security Service Union Food and Drug Administration regulations have long allowed drug companies to give educational grants to individuals or groups that discuss or promote off-label uses. But in recent years, federal prosecutors have been investigating whether these activities have strayed beyond educational purposes and violated antikickback statutes or resulted in the government's spending money in its Medicare and Medicaid health programs for prescriptions that were not warranted.

Credit Report Service In one example cited in the committee's letter, Johnson & Johnson in 1999 provided an "educational" grant to pay for an alumni reception at the annual meeting of a medical specialty society.

Blogspot Com Christian That grant was provided at the request of a physician who had previously received grant money for research and educational activities related to Propulsid, a Johnson & Johnson drug that was withdrawn in 2000 after it was found to cause potentially fatal heart arrhythmias. Although Propulsid was approved only to treat severe heartburn in adults, it ended up being widely prescribed for off-label use by children.

Christian Counseling Credit The committee's letter seeks information beyond what Johnson & Johnson has already provided investigators. Jeffrey Leebaw, a company spokesman, declined to comment, beyond saying, "We are in receipt of the letter and will cooperate with the committee's request for additional information."

Credit Federal Service Union Ken Johnson, a senior vice president for the industry's main trade group, the Pharmaceutical Research and Manufacturers of America, said drug makers' decisions about awarding educational grants were up to the individual companies. "We do, however, offer comprehensive voluntary guidelines to our member companies that are designed to help keep marketing practices ethical," he said.

Credit Monitoring Service Some companies have said that they have revamped their grant-making procedures recently, taking the power to bestow grants out of the hands of marketing executives and giving it instead to executives in the companies' medical divisions.

Credit Division Service But the committee found that these changes had not been universally adopted.

Card Credit Online Service "It appears that many manufacturers' sales and/or marketing personnel still have a role in originating or evaluating grant requests," the committee's letter to Johnson & Johnson said.

Consumer Counseling Credit Inc The letter asked pointed questions about the company's efforts to promote Propulsid, particularly among children.

Card Credit Fleet Service Days before the committee's investigation began last summer, an article in The New York Times detailed how Johnson & Johnson gave grants to doctors, medical societies and patient advocacy groups that promoted Propulsid's use in children. The drug was widely prescribed by pediatricians, even though Propulsid was never shown to be effective in children, was never approved by federal regulators for use in children, and may have been particularly toxic to children.

Card Consolidation Credit The committee's letter to Johnson & Johnson said that information that the company had earlier given to the committee about its "efforts to promote the use of Propulsid in children raises additional questions."

Credit Free Online Report The committee found, for example, that the company's educational grants were being authorized by executives with titles that included product director, gastroenterology product director, Propulsid brand product director and director of segment marketing.

Credit Federal First Service "Most, if not all, of these titles appear to relate to positions involved in sales and/or marketing," the letter noted. And it said many of the grants that Johnson & Johnson provided relating to Propulsid "have no apparent relation to education."

Consumer Credit Service The letter noted that from 1996 through 1999 Johnson & Johnson provided more than $1.3 million to a patient advocacy organization that had almost no financing from any other source. The group folded in 2000 after Propulsid was withdrawn.

Center Credit Family Service The letter does not identify this group, but the details match those of the American Pseudo-Obstruction and Hirschsprung's Disease Society. The group helped to train speakers who, over three years, made presentations to 6,000 to 8,000 pediatric doctors and nurses about the treatment of childhood reflux, recommending Propulsid.

Credit Reporting Service The letter also noted that Johnson & Johnson provided significant financing to three medical societies that it did not identify. The level of financing was such that these groups "may become so reliant on industry funding that it may compromise their independence," the letter stated.

[ Comment, Edit or Article Submission ]